Protagonist Therapeutics PTGX
NASDAQ PTGX
$140.89 -0.08 (-0.06%)
At close: Sep 30, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) EV to CFO (2017 - 2026)

Updated

Protagonist Therapeutics' (PTGX) EV to CFO came in at 54.46 for Q2 2026, down 24.8% from 72.38 a year earlier.

Analysis

Protagonist Therapeutics (PTGX) EV to CFO (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to CFO at Protagonist Therapeutics was 41.57, up 17.4% year-over-year; for FY2025, it was 84.93, up 707.5% from FY2024.

  • In prior years, Protagonist Therapeutics' EV to CFO was 10.52 in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly EV to CFO since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Protagonist Therapeutics 9.11 Bn 9.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.46
Dec 31, 2025 84.93
Sep 30, 2025 54.56
Jun 30, 2025 72.38
Mar 31, 2025 7.18
Dec 31, 2024 10.52
Sep 30, 2024 9.60
Jun 30, 2024 6.36
Dec 31, 2017 76.09
Sep 30, 2017 24.68
API Access

Protagonist Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PTGX&period=max&api_key=YOUR_API_KEY